Skip to content

Serratus Posterior Superior Intercostal Plane Block in Port Catheter Implantation

Comparison of Serratus Posterior Superior Intercostal Plane Block and Local Infiltration for Analgesia During Port Catheter Implantation: A Prospective Randomized Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07579572
Enrollment
70
Registered
2026-05-12
Start date
2026-05-16
Completion date
2026-06-16
Last updated
2026-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain, Vascular Access Device

Keywords

Postoperative Pain, Serratus posterior superior intercostale plane block

Brief summary

This randomized prospective study aims to compare the analgesic efficacy of serratus posterior superior intercostal plane (SPSIP) block and standard local anesthetic infiltration in patients undergoing port catheter implantation.

Detailed description

This prospective, randomized controlled study evaluates the analgesic efficacy of the serratus posterior superior intercostal plane (SPSIP) block compared with standard local anesthetic infiltration in patients undergoing port catheter implantation. Although the procedure is usually performed under local anesthesia, patients may experience significant pain during port pocket creation. Participants will be randomized in a 1:1 ratio to receive either ultrasound-guided SPSIP block or local anesthetic infiltration. All patients will receive standardized monitoring and premedication. Pain intensity during different procedural stages, postoperative pain scores, analgesic consumption, and satisfaction levels will be assessed. The study aims to determine whether SPSIP block improves intraoperative analgesia and reduces analgesic requirements compared to local infiltration.

Interventions

PROCEDURESerratus Posterior Superior Intercostal Plane Block

Ultrasound-guided Serratus Posterior Superior Intercostal plane block performed prior to the procedure.

Standard local anesthetic infiltration performed at the surgical site during port catheter implantation.

Sponsors

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Participants and care providers will not be blinded due to the nature of the interventions. Investigators responsible for data analysis and outcome assessors responsible for postoperative evaluations will be blinded to group allocation.

Intervention model description

Participants will be randomly assigned in a 1:1 ratio to receive either ultrasound-guided Serratus Posterior Superior Intercostal Plane Block (SPSIP block) or local anesthetic infiltration. Both groups will undergo the procedure under standardized conditions, and outcomes will be compared between parallel groups.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-75 years * ASA physical status I-III * Scheduled for elective port catheter implantation * Ability to understand and use the Numeric Rating Scale (NRS) * Provided written informed consent

Exclusion criteria

* Known allergy to local anesthetics * Infection at the injection site * Coagulopathy or anticoagulant therapy * Severe pulmonary disease * G6PD deficiency * Pregnancy or breastfeeding * Inability to assess pain or communicate effectively * Refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
Pain intensity during port pocket creationDuring procedurePain intensity during port pocket creation measured using the Numeric Rating Scale (0-10), where higher scores indicate greater pain. Numeric Rating Scale (NRS; 0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain.

Secondary

MeasureTime frameDescription
Maximum intraoperative pain scoreDuring the procedureThe highest pain intensity recorded during any procedural stage will be assessed using the Numeric Rating Scale (NRS; 0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Pain intensity during procedural stagesDuring the procedurePain intensity will be assessed during skin puncture, catheter tunneling, and skin closure using the Numeric Rating Scale (NRS; 0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Total supplemental local anesthetic amountDuring the procedureTotal amount of additional local anesthetic administered during the procedure will be recorded in milliliters.
Postoperative pain scores0, 2, 6, 12, and 24 hours after the procedurePostoperative pain intensity will be assessed using the Numeric Rating Scale (NRS; 0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Total tramadol consumptionWithin 24 hours after the procedureTotal intravenous tramadol consumption within the first 24 hours after the procedure will be recorded in milligrams.
Duration of effective analgesiaWithin 24 hours after the procedureDuration of effective analgesia will be defined as the time interval from completion of the procedure to the first administration of rescue analgesia.
Patient satisfaction scoreAfter the procedurePatient satisfaction will be assessed using a 5-point Likert scale, where 1 indicates very dissatisfied and 5 indicates very satisfied. Higher scores indicate greater satisfaction.
Surgeon satisfaction scoreAfter the procedureSurgeon satisfaction will be assessed using a 5-point Likert scale, where 1 indicates very dissatisfied and 5 indicates very satisfied. Higher scores indicate greater satisfaction.
Procedure-related complicationsDuring and within 24 hours after the procedureProcedure-related complications, including pneumothorax, hematoma, local anesthetic systemic toxicity, methemoglobinemia, and infection, will be recorded.

Countries

Turkey (Türkiye)

Contacts

CONTACTFatma Acil, M.D.
acilfatma@gmail.com+905337225225
PRINCIPAL_INVESTIGATORFatma Acil, M.D.

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 20, 2026